Nordmark Biotech at the German Biotechnology Days 2022
The German biotechnology industry will meet again on 4th and 5th May 2022 - for the second time in Hamburg. Nordmark Biotech will again be represented with a stand. In addition, the managing director of the Nordmark subsidiary BIBITEC will take part in an exciting discussion about Germany as a production location at the DBT.
With its countless innovative application possibilities, biotechnology holds immense potential and is booming unabated worldwide. Every year, the German Biotechnology Days, or DBT for short, provide a national platform for important exchanges between companies, science, politics and funding institutions. This year's host of the German Biotechnology Days at Hamburg is Life Science Nord. Since 2010, the organisers of the DBT have been the industry association of the German biotechnology industry, BIO Deutschland e. V., and the Working Group of German BioRegions.
Nordmark on the DBT
The company from Uetersen is a regular participant at the DBT. This year, visitors to the Nordmark Biotech stand can expect an information portfolio that is visually and informatively divided into two central areas: the production of active ingredients using microbial fermentation and from mammalian cells. A video literally gives visitors an interesting insight into the complex manufacturing processes of Nordmark Biotech products. Fun is provided by small cuddly bacteria and mammalian cells waiting to be taken away at the stand.
Germany as a biotech production location: what's working, what's missing?
These are very legitimate questions and therefore the title of a symposium at the DBT. Germany has lost some of its attractiveness as a production location for biotechnological medicines. Instead of ranking second internationally, as it used to, it now ranks fifth. This is undoubtedly still a good ranking and still at the top of the world, but domestic production capacities are indispensable and are becoming increasingly important. The recent supply bottlenecks caused by the Corona pandemic have made this clear. So there is an urgent need for action. But how can Germany be secured and expanded as a production location? And how realistic is it to bring back the production capacities that have been transferred to other countries?